Quantitative MRI of Perivascular Spaces at 3T for Early Diagnosis of Mild Cognitive Impairment

References

1. 1.↵
   2. Virchow R

   . Ueber die Erweiterung kleinerer Gefäfse. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin 1851;3:427–62
2. 2.↵
   2. Heier LA,
   3. Bauer CJ,
   4. Schwartz L, et al

   . Large Virchow-Robin spaces: MR-clinical correlation. AJNR Am J Neuroradiol 1989;10:929–36 pmid:2505536

   Abstract/FREE Full Text
3. 3.↵
   2. Rolyan H,
   3. Feike AC,
   4. Upadhaya AR, et al

   . Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease. J Neural Transm 2011;118:699–712 doi:10.1007/s00702-010-0572-7 pmid:21210284

   CrossRefPubMed
4. 4.↵
   2. Salzman KL,
   3. Osborn AG,
   4. House P, et al

   . Giant tumefactive perivascular spaces. AJNR Am J Neuroradiol 2005;26:298–305 pmid:15709127

   Abstract/FREE Full Text
5. 5.↵
   2. Davis PC,
   3. Mirra SS,
   4. Alazraki N

   . The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol 1994;162:1267–78 doi:10.2214/ajr.162.6.8191980 pmid:8191980

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Miyakawa T,
   3. Hattori E,
   4. Shikai I, et al

   . Histopathological changes of chronic alcoholism. Folia Psychiatr Neurol Jpn 1977;31:253–61 pmid:903042

   PubMed
7. 7.↵
   2. Poirier J,
   3. Derouesné C

   . Distinguishing lacunar infarcts from dilatations of the perivascular space. J Neurol 1998;245:813–14 doi:10.1007/s004150050293 pmid:9840356

   CrossRefPubMed
8. 8.↵
   2. Achiron A,
   3. Faibel M

   . Sandlike appearance of Virchow-Robin spaces in early multiple sclerosis: a novel neuroradiologic marker. AJNR Am J Neuroradiol 2002;23:376–80 pmid:11901003

   Abstract/FREE Full Text
9. 9.↵
   2. Flicker C,
   3. Ferris SH,
   4. Reisberg B

   . Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991;41:1006–09 doi:10.1212/WNL.41.7.1006 pmid:2067629

   Abstract/FREE Full Text
10. 10.↵
    2. Tierney MC,
    3. Szalai JP,
    4. Snow WG, et al

    . Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 1996;46:661–65 doi:10.1212/WNL.46.3.661 pmid:8618663

    FREE Full Text
11. 11.↵
    2. Devanand DP,
    3. Folz M,
    4. Gorlyn M, et al

    . Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 1997;45:321–28 doi:10.1111/j.1532-5415.1997.tb00947.x pmid:9063278

    CrossRefPubMedWeb of Science
12. 12.↵
    2. Bowen J,
    3. Teri L,
    4. Kukull W, et al

    . Progression to dementia in patients with isolated memory loss. Lancet 1997;349:763–65 doi:10.1016/S0140-6736(96)08256-6 pmid:9074575

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Petersen RC

    . Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274–78 pmid:7646655

    CrossRefPubMedWeb of Science
14. 14.↵
    2. Sherwin BB

    . Mild cognitive impairment: potential pharmacological treatment options. J Am Geriatr Soc 2000;48:431–41 doi:10.1111/j.1532-5415.2000.tb04703.x pmid:10798472

    CrossRefPubMedWeb of Science
15. 15.↵
    2. O'Bryant SE,
    3. Humphreys JD,
    4. Smith GE, et al

    . Detecting dementia with the Mini-Mental State Examination in highly educated individuals. Arch Neurol 2008;65:963–67 pmid:18625866

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Herlitz A

    . Detection of mild dementia in community surveys: is it possible to increase the accuracy of our diagnostic instruments? Arch Neurol 1997;54:319–24 doi:10.1001/archneur.1997.00550150075019 pmid:9074402

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Stewart R

    . Mild cognitive impairment: the continuing challenge of its “real-world” detection and diagnosis. Arch Med Res 2012;43:609–14 doi:10.1016/j.arcmed.2012.10.011 pmid:23127423

    CrossRefPubMed
18. 18.↵
    2. Mueller SG,
    3. Weiner MW,
    4. Thal LJ, et al

    . The Alzheimer's Disease Neuroimaging Initiative. Neuroimaging Clin N Am 2005;15:869–77 doi:10.1016/j.nic.2005.09.008 pmid:16443497

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Chen W,
    3. Song X,
    4. Zhang Y

    . Assessment of the Virchow-Robin Spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging. AJNR Am J Neuroradiol 2011;32:1490–95 doi:10.3174/ajnr.A2541 pmid:21757525

    Abstract/FREE Full Text
20. 20.↵
    2. Ramirez J,
    3. Berezuk C,
    4. McNeely AA, et al

    . Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer's disease patients and normal elderly from the Sunnybrook Dementia Study. J Alzheimers Dis 2015;43:415–24 doi:10.3233/JAD-132528 pmid:25096616

    CrossRefPubMed
21. 21.↵
    2. Hernández Mdel C,
    3. Piper RJ,
    4. Wang X, et al

    . Towards the automatic computational assessment of enlarged perivascular spaces on brain magnetic resonance images: a systematic review. J Magn Reson Imaging 2013;38:774–85 doi:10.1002/jmri.24047 pmid:23441036

    CrossRefPubMed
22. 22.↵
    2. Doubal FN,
    3. MacLullich AM,
    4. Ferguson KJ, et al

    . Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke 2010;41:450–54 doi:10.1161/STROKEAHA.109.564914 pmid:20056930

    Abstract/FREE Full Text
23. 23.↵
    2. Cai K,
    3. Tain R,
    4. Das S, et al

    . The feasibility of quantitative MRI of perivascular spaces at 7T. J Neurosci Methods 2015;256:151–56 doi:10.1016/j.jneumeth.2015.09.001 pmid:26358620

    CrossRefPubMed
24. 24.↵
    2. Yushkevich PA,
    3. Pluta JB,
    4. Wang H, et al

    . Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp 2015;36:258–87 doi:10.1002/hbm.22627 pmid:25181316

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Grundman M,
    3. Petersen RC,
    4. Ferris SH, et al

    ; Alzheimer's Disease Cooperative Study. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59–66 doi:10.1001/archneur.61.1.59 pmid:14732621

    CrossRefPubMedWeb of Science
26. 26.↵
    2. Csukly G,
    3. Sirály E,
    4. Fodor Z, et al

    . The differentiation of amnestic type MCI from the non-amnestic types by structural MRI. Front Aging Neurosci 2016;8:52 doi:10.3389/fnagi.2016.0005 pmid:27065855

    CrossRefPubMed
27. 27.↵
    2. Petersen RC

    . Mild cognitive impairment as a diagnostic entity. J Intern Med 2004;256:183–94

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Cai K,
    3. Shore A,
    4. Singh A, et al

    . Blood oxygen level dependent angiography (BOLDangio) and its potential applications in cancer research. NMR Biomed 2012;25:1125–32 doi:10.1002/nbm.2780 pmid:22302557

    CrossRefPubMed
29. 29.↵
    2. Trattnig S,
    3. Springer E,
    4. Bogner W, et al

    . Key clinical benefits of neuroimaging at 7T. Neuroimage 2018;168:477–89 doi:10.1016/j.neuroimage.2016.11.031 pmid:27851995

    CrossRefPubMed
30. 30.↵
    2. Roberts R,
    3. Knopman DS

    . Classification and epidemiology of MCI. Clin Geriatr Med 2013;29:753–72 doi:10.1016/j.cger.2013.07.003 pmid:24094295

    CrossRefPubMed
31. 31.↵
    2. Kantarci K,
    3. Weigand SD,
    4. Przybelski SA, et al

    . Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology 2009;72:1519–25 doi:10.1212/WNL.0b013e3181a2e864 pmid:19398707

    Abstract/FREE Full Text
32. 32.↵
    2. Mitchell AJ,
    3. Shiri-Feshki M

    . Rate of progression of mild cognitive impairment to dementia–meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 2009;119:252–65 doi:10.1111/j.1600-0447.2008.01326.x pmid:19236314

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Ward A,
    3. Tardiff S,
    4. Dye C, et al

    . Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature. Dement Geriatr Cogn Dis Extra 2013;3:320–32 doi:10.1159/000354370 pmid:24174927

    CrossRefPubMed
34. 34.↵
    2. Apostolova LG,
    3. Green AE,
    4. Babakchanian S, et al

    . Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer disease. Alzheimer Dis Assoc Disord 2012;26:17–27 doi:10.1097/WAD.0b013e3182163b62 pmid:22343374

    CrossRefPubMed
35. 35.↵
    2. Jack CR Jr.,
    3. Shiung MM,
    4. Gunter JL, et al

    . Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591–600 doi:10.1212/01.WNL.0000110315.26026.EF pmid:14981176

    Abstract/FREE Full Text
36. 36.↵
    2. Parikh R,
    3. Mathai A,
    4. Parikh S, et al

    . Understanding and using sensitivity, specificity and predictive values. Indian J Ophthalmol 2008;56:45–50 doi:10.4103/0301-4738.37595 pmid:18158403

    CrossRefPubMed
37. 37.↵
    2. Press GA,
    3. Murakami JW,
    4. Courchesne E, et al

    . The cerebellum, 3: anatomic-MR correlation in the coronal plane. AJNR Am J Neuroradiol 1990;11:41–50 pmid:2105616

    Abstract/FREE Full Text